|
|
|
Alzheimers causes a slow loss of brain cells resulting in the loss of many cognitive abilities. Recognizing the symptoms is often difficult and easily missed because of the resemblance to natural signs of aging. People with Alzheimers exhibit a number of different symptoms. Symptoms of Alzheimers progress over time. In the early stages, family members and friends may notice minor personality changes. If you suspect someone you know has the disease, here are some signs to look for: * Loss of short-term memory. Forgetting newly learned information is one of the most common early indications of Alzheimers. People with Alzheimers often misplace everyday objects such as keys. In early stages, they may have slight changes in attention span and minor language difficulties. * Trouble with common tasks. For people with Alzheimers, routine tasks - such as cooking, shopping or paying bills - become increasingly difficult and frustrating. * Confusion with times and dates. Some people with Alzheimers disease forget where they are, even in their own home. They may also forget details of events or appointments. As the disease progresses, patients have trouble recognizing family members or friends. * Disorientation. Alzheimers patients may get lost or confused in familiar places and may wander off. In the final stages of Alzheimers disease, patients lose cognition and personality along with the ability to care for themselves and become more vulnerable to other illnesses. While there is no cure for Alzheimers disease yet, scientists are working on new ways to detect and diagnose the disease before these symptoms surface. One significant area of research in Alzheimers and other neurodegenerative diseases is proteomics. Proteomics is the study and analysis of proteins, the fundamental building blocks of the human body. By studying proteins, scientists can understand more fully the functioning of a healthy body and identify the proteins associated with specific diseases. Power3 Medical (OTC BB: PWRM), a leader in proteomics research, has developed a promising Neurodegenerative Screening Test, which involves monitoring the concentration of a panel of proteins in the blood. According to the company, they are able to identify unique biomarkers whose profiles appear to distinguish patients with Lou Gehrigs (ALS), Alzheimers and Parkinsons diseases from each other as well as from the normal individuals and patients with other neurological disorders. Power3 Medical believes this test will give doctors the ability to diagnose these diseases before irreversible brain damage occurs - potentially providing the opportunity to delay their progression and the clues to design new drugs to treat the disease earlier. |
加入最爱